top of page

Experts encourage better 'cyber hygiene' as pharma breaches skyrocket amid the pandemic

Updated: Mar 23

The potential cost of a cyberattack should be incentive enough. According to Constella, the average cost per breach in the pharma sector is $5 million. Bigger attacks, however, cause much more damage. In 2017, ransomware dubbed NotPetya eliminated years of research at Merck and crippled Gardasil 9 production facilities, forcing the company to dip into the US national stockpile. And though Merck wasn’t even the intended target of the ransomware, the pharma giant still suffered more than $1.4 billion in losses as a result.


In a worst-case scenario, Charles Fracchia told Endpoints News a couple of weeks ago that a targeted attack could crumble “virtually all biomanufacturing infrastructure in the US” overnight.



Recent Posts

See All
logo of bio-isac, dark green and light green spiral looking like a graphic representation of DNA and the words bioisac creating collaborative threat intelligence for the bioeconomy

Connect with us:
tips@isac.bio

Subscribe to Our Updates

Follow Us

  • LinkedIn

© 2025 by BIO-ISAC. All rights reserved.


BIO-ISAC is a 501(c)3 organization.

bottom of page